Latest FluoGuide News & Updates
See the latest news and media coverage for FluoGuide. We track all announcements, press releases, and industry mentions in real time, all in one place.
Biotechnology company developing fluorescent cancer surgery drugs
fluoguide.com- Headquarters
- Copenhagen, Denmark
- Founded year
- 2018
- Company type
- Private company
- Number of employees
- 2–15
Latest news about FluoGuide
Company announcements
-
FluoGuide presents positive interim FG001 study results
Dr. Jane Skjøth-Rasmussen shared data at Brain Tumor Symposium 2026 in Copenhagen, highlighting FG001's potential to improve tumor delineation in meningioma and low-grade glioma surgery.
-
FluoGuide presents positive interim FG001 study results
Interim data show 100% sensitivity in meningioma surgery and encouraging fluorescence in low-grade glioma. Presented at SNOG 2026.
-
FluoGuide holds annual general meeting
The meeting adopts the 2025 annual report, re-elects board members, elects new member Kim D. Kjøller, authorizes warrants, updates articles of association, and approves board remuneration.
-
FluoGuide receives FDA Fast Track Designation for FG001
The designation facilitates FG001's development as an intraoperative imaging agent for high-grade glioma resection. It enables frequent FDA interactions and potential accelerated approval. Phase 2 trial preparation is underway.
Media coverage
-
FluoGuide A/S: Positive interim results from an investigator-initiated study of FG001 in meningioma and low-grade glioma surgery, re-presented at SNOG
Copenhagen, Denmark, 10 April 2026 - FluoGuide A/S ("FluoGuide" or the "Company"), a clinical-stage biotech company maximizing surgical outcomes in oncology by lighting up cancer...
-
FluoGuide Receives FDA Fast Track Designation for FG001 in High-Grade Glioma
COPENHAGEN, DENMARK / ACCESS Newswire / March 18, 2026 / FluoGuide A/S (STO:FLUO) ("FluoGuide" or the "Company"), a biotech company maximizing surgical outcomes in oncology...
-
Notice of Annual General Meeting in FluoGuide A/S
7.1 Authorisation to the board of directors to issue warrants for employees, consultants and advisors 7.2 Authorisation to the board of directors to issue warrants...
-
FluoGuide A/S Publishes Annual Report For The Fiscal Year 2025
COPENHAGEN, DK / ACCESS Newswire / February 25, 2026 / FluoGuide A/S ("FluoGuide" or the "Company")(STO:FLUO) hereby publishes its annual report for the fiscal year...
Track FluoGuide and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
FluoGuide competitors & trending companies
Browse news for competitors to FluoGuide and other trending companies.
Ascelia Pharma
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore
BlueConic
Amperity
Wero
BLIK
EPI
Swish
Affirm
Brite Payments
TCS
Overview Energy
Adfin
Ineffable Intelligence
Mechanize
Hexatronic
Alimak Group
Lindab Group
NYAB
Noon Energy
Nordan AI
Mips
Vexlum
Asker Healthcare Group